MicroBase Technology Corp. (TPEX:3184)

Market Cap	1.72B +113.4%
Revenue (ttm)	211.70M -1.4%
Net Income	30.14M -56.6%
EPS	0.48 -56.4%
Shares Out	63.07M
PE Ratio	56.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,660,287
Average Volume	3,058,819
Open	29.45
Previous Close	29.65
Day's Range	26.00 - 30.00
52-Week Range	8.40 - 35.90
Beta	0.41
RSI	56.37
Earnings Date	Aug 12, 2026

About MicroBase Technology

MicroBase Technology Corp. engages in the research, design, manufacture, and sale of components and products of micro-atomization and micro-needles for medical, cosmetic and electronic applications in Taiwan. The company develops non-silicon-based micro-electro-mechanical systems. It offers industrial inkjet head; soft mist inhaler, for the treatment of chronic obstructive pulmonary disease, lower respiratory tract infections, and chronic respiratory diseases; Pocket Air, an aerosol drug delivery solution; and soluble and insoluble microneedles...

• Industry: Electronic Components
• Sector: Technology
• Founded: 1997
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3184

Financial Performance

In 2025, MicroBase Technology's revenue was 211.70 million, a decrease of -1.43% compared to the previous year's 214.76 million. Earnings were 30.14 million, a decrease of -56.59%.